Gwen Murphy1, Sanford M Dawsey2, Eric A Engels2, Winnie Ricker3, Ruth Parsons3, Arash Etemadi2, Shih-Wen Lin2, Christian C Abnet2, Neal D Freedman2. 1. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: murphygw@mail.nih.gov. 2. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 3. Information Management Services, Inc, Calverton, Maryland.
Abstract
BACKGROUND & AIMS: Pernicious anemia, a result of autoimmune gastritis, is the most common cause of vitamin B12 deficiency, affecting 2% to 5% of the elderly population. Treatment with vitamin B12 cures the anemia, but not the gastritis. Findings from small studies have indicated that patients with pernicious anemia could have an increased risk of cancer. METHODS: We performed a population-based, case-control study of individuals in the Surveillance, Epidemiology, and End Results-Medicare database, comparing 1,138,390 cancer cases (age, 66-99 y) with 100,000 matched individuals without cancer (controls). Individuals with pernicious anemia were identified based on their medical claims within the year before selection for the study. Odds ratios (OR) and 95% confidence intervals (CI) were calculated using unconditional logistic regression, and models were adjusted for sex, age, and calendar year of diagnosis and selection. RESULTS: Compared with controls, we found individuals with pernicious anemia to be at increased risk for noncardia gastric adenocarcinoma (OR, 2.18; 95% CI, 1.94-2.45) and gastric carcinoid tumors (OR, 11.43; 95% CI, 8.90-14.69). In addition, people with pernicious anemia have an increased risk of developing tonsilar cancer (OR, 2.00; 95% CI, 1.40-2.85), hypopharyngeal cancer (OR, 1.92; 95% CI, 1.35-2.73), esophageal squamous cell carcinoma (OR, 2.12; 95% CI, 1.76-2.55), small intestinal cancer (OR, 1.63; 95% CI, 1.32-2.02), liver cancer (OR, 1.49; 95% CI, 1.28- 1.73), myeloma (OR, 1.55; 95% CI, 1.37-1.75), acute myeloid leukemia (OR, 1.68; 95% CI, 1.46-1.93), and myelodysplastic syndrome (OR, 2.87; 95% CI, 2.53-3.26). People with pernicious anemia have a lower risk of rectal cancer than the general population (OR, 0.82; 95% CI, 0.74- 0.92). CONCLUSIONS: In a population-based, case-control study of individuals in the Surveillance, Epidemiology, and End Results-Medicare database, we found individuals with pernicious anemia to have significantly increased risks of gastric carcinoid tumors, adenocarcinomas, and other cancers located throughout the body.
BACKGROUND & AIMS:Pernicious anemia, a result of autoimmune gastritis, is the most common cause of vitamin B12 deficiency, affecting 2% to 5% of the elderly population. Treatment with vitamin B12 cures the anemia, but not the gastritis. Findings from small studies have indicated that patients with pernicious anemia could have an increased risk of cancer. METHODS: We performed a population-based, case-control study of individuals in the Surveillance, Epidemiology, and End Results-Medicare database, comparing 1,138,390 cancer cases (age, 66-99 y) with 100,000 matched individuals without cancer (controls). Individuals with pernicious anemia were identified based on their medical claims within the year before selection for the study. Odds ratios (OR) and 95% confidence intervals (CI) were calculated using unconditional logistic regression, and models were adjusted for sex, age, and calendar year of diagnosis and selection. RESULTS: Compared with controls, we found individuals with pernicious anemia to be at increased risk for noncardia gastric adenocarcinoma (OR, 2.18; 95% CI, 1.94-2.45) and gastric carcinoid tumors (OR, 11.43; 95% CI, 8.90-14.69). In addition, people with pernicious anemia have an increased risk of developing tonsilar cancer (OR, 2.00; 95% CI, 1.40-2.85), hypopharyngeal cancer (OR, 1.92; 95% CI, 1.35-2.73), esophageal squamous cell carcinoma (OR, 2.12; 95% CI, 1.76-2.55), small intestinal cancer (OR, 1.63; 95% CI, 1.32-2.02), liver cancer (OR, 1.49; 95% CI, 1.28- 1.73), myeloma (OR, 1.55; 95% CI, 1.37-1.75), acute myeloid leukemia (OR, 1.68; 95% CI, 1.46-1.93), and myelodysplastic syndrome (OR, 2.87; 95% CI, 2.53-3.26). People with pernicious anemia have a lower risk of rectal cancer than the general population (OR, 0.82; 95% CI, 0.74- 0.92). CONCLUSIONS: In a population-based, case-control study of individuals in the Surveillance, Epidemiology, and End Results-Medicare database, we found individuals with pernicious anemia to have significantly increased risks of gastric carcinoid tumors, adenocarcinomas, and other cancers located throughout the body.
Authors: S J Weinstein; R G Ziegler; J Selhub; T R Fears; H D Strickler; L A Brinton; R F Hamman; R S Levine; K Mallin; P D Stolley Journal: Cancer Causes Control Date: 2001-05 Impact factor: 2.506
Authors: Rebecca L Sedjo; Paula Inserra; Martha Abrahamsen; Robin B Harris; Denise J Roe; Susie Baldwin; Anna R Giuliano Journal: Cancer Epidemiol Biomarkers Prev Date: 2002-04 Impact factor: 4.254
Authors: William F Anderson; Charles S Rabkin; Natalie Turner; Joseph F Fraumeni; Philip S Rosenberg; M Constanza Camargo Journal: J Natl Cancer Inst Date: 2018-06-01 Impact factor: 13.506
Authors: Gwen Murphy; Christian C Abnet; Hyoyoung Choo-Wosoba; Emily Vogtmann; Stephanie J Weinstein; Philip R Taylor; Satu Männistö; Demetrius Albanes; Sanford M Dawsey; Jens F Rehfeld; Neal D Freedman Journal: Int J Epidemiol Date: 2017-06-01 Impact factor: 7.196
Authors: Matthew Banks; David Graham; Marnix Jansen; Takuji Gotoda; Sergio Coda; Massimiliano di Pietro; Noriya Uedo; Pradeep Bhandari; D Mark Pritchard; Ernst J Kuipers; Manuel Rodriguez-Justo; Marco R Novelli; Krish Ragunath; Neil Shepherd; Mario Dinis-Ribeiro Journal: Gut Date: 2019-07-05 Impact factor: 23.059
Authors: Eugenia H Miranti; Rachael Stolzenberg-Solomon; Stephanie J Weinstein; Jacob Selhub; Satu Männistö; Philip R Taylor; Neal D Freedman; Demetrius Albanes; Christian C Abnet; Gwen Murphy Journal: Int J Cancer Date: 2017-06-21 Impact factor: 7.396
Authors: Shao-Ming Wang; Mark J Roth; Gwen A Murphy; Sanford M Dawsey; Jin-Hu Fan; Philip R Taylor; You-Lin Qiao; Christian C Abnet Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-09-09 Impact factor: 4.254
Authors: Jorge L Sepulveda; Jorge L Gutierrez-Pajares; Aesis Luna; Yuan Yao; John W Tobias; Steven Thomas; Yanghee Woo; Federico Giorgi; Elena V Komissarova; Andrea Califano; Timothy C Wang; Antonia R Sepulveda Journal: Mod Pathol Date: 2016-01-15 Impact factor: 7.842